Viridian Therapeutics, Inc.\DE ($VRDN)
Filing Information
| Accession Number | 0001193125-26-092074 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
155,212
Total Value
$50,547.68
P&L
+inf% (+$3,862,187.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 5,169 | โ | โ | 5,169 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Mar 3, 2026 | Tax Withholding | 1,724 | $29.32 | $50,547.68 | 3,445 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | Mar 2, 2026 | Grant/Award | 119,300 | $0.00 | $0.00 | 119,300 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Mar 2, 2026 | Grant/Award | 23,850 | $0.00 | $0.00 | 23,850 | Direct | โ | View Details | |
Chief Legal Officer | Restricted Stock Units | Derivative | Mar 3, 2026 | Exercise/Conversion | 5,169 | $0.00 | $0.00 | 15,510 | Direct | โ | View Details |